Insurance Coverage for Ketamine Therapy in 2026: What Patients and Providers Need to Know
The number one question patients ask before booking ketamine therapy is simple: does insurance cover this? The answer depends on the type of ketamine treatment. FDA approved Spravato (esketamine nasal spray) now carries coverage from every major commercial insurer. IV ketamine infusions remain almost entirely out of pocket. This guide breaks down exactly what each treatment costs, which insurers cover what, and how patients and clinics navigate the financial side of ketamine therapy in 2026. Do you work in the ketamine industry? Save thousands on overhead and other fees by joining the first GPO for ketamine clinics and practitioners. There’s no cost to join and zero obligations. Sign up here!| Key Takeaway | What It Means |
|---|---|
| Spravato carries broad insurance coverage | All 18 major commercial insurers have written policies covering Spravato for treatment resistant depression |
| IV ketamine remains out of pocket | Most insurers classify IV ketamine as off label and experimental for mental health conditions |
| Prior authorization is universal | Every insurer requires prior auth for Spravato, typically taking 1 to 3 weeks |
| HSA and FSA funds cover ketamine | Patients can use pretax health accounts for both IV ketamine and Spravato with proper documentation |
| Superbills offer partial reimbursement | Patients submitting superbills for out of network IV ketamine report recovering 20% to 50% of costs |
| 2026 parity rules expand protections | New federal mental health parity standards require insurers to justify treatment limitations for mental health equally against physical health |
National Ketamine Cost & Access Snapshot
Sources: HealingMaps Clinic Intelligence Report 2026 · CDC PLACES 2023 · r/TherapeuticKetamine patient pricing corpus · 132 clinic website pricing scrapes · 658 practitioner survey responses.
- Median per-session cost (patient reported): $350, typical range $150 to $500
- IV Ketamine median: $450 per session (range $300 to $800)
- IM Ketamine median: $350 per session (range $200 to $500)
- Spravato (esketamine) cash-pay median: $750 per session (range $590 to $885 pre-insurance)
- KAP (ketamine-assisted psychotherapy) median: $650 per session (range $400 to $1,200)
- Patients with zero insurance coverage for ketamine: 75%
- Patients citing access as the #1 barrier to treatment: 44.9%
- Patients reporting at-home ketamine is “a bad idea”: 64.8%
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
Ketamine Insurance Cost Calculator
How Much Will Ketamine Therapy Cost?
Estimate your out-of-pocket range based on patient-reported pricing and HealingMaps proprietary clinic data.
Estimated per session
—
—
Estimated total program
—
—
Select a treatment type to see pricing context.
IV Ketamine Infusions: Why Insurance Rarely Covers Them
IV ketamine infusions treat depression, PTSD, anxiety, and chronic pain with strong clinical results. Insurance companies still classify this use as off label because the FDA approved ketamine only as an anesthetic. That off label designation gives insurers grounds to deny claims. Most clinics operate on a cash pay model for IV ketamine. Patients pay the full cost upfront and receive treatment without waiting for insurance approval. This removes barriers to access but places the financial burden entirely on the patient. Some insurers cover IV ketamine for chronic pain under specific medical codes. Coverage for psychiatric indications remains rare. Patients pursuing IV ketamine for depression should plan to pay out of pocket and explore the reimbursement strategies outlined below.Spravato (Esketamine): The Insured Option
Spravato changed the coverage landscape when the FDA approved it in 2019 for treatment resistant depression. A second approval followed for major depressive disorder with acute suicidal ideation. These FDA approvals forced insurers to establish coverage policies. Learn more about how Spravato is reshaping psychedelic adjacent care on HealingMaps. In a 2025 review of 18 major commercial insurers, every single one maintained a written policy covering Spravato. Coverage requires treatment at a REMS certified healthcare facility where patients remain under observation for at least two hours after each dose. Spravato coverage comes with conditions. Patients must demonstrate a qualifying diagnosis and document failed trials of other antidepressants. The clinic must hold REMS certification. Every insurer requires prior authorization before the first treatment session.What Prior Authorization Requires
Prior authorization acts as the gatekeeper between patients and covered Spravato treatment. Clinicians submit documentation proving the patient meets specific clinical criteria. The process typically takes one to three weeks. Every major insurer requires the following for Spravato prior authorization:- A confirmed diagnosis of treatment resistant depression or MDD with suicidal ideation
- Documentation of failed antidepressant trials (the number varies by insurer)
- Treatment administered at a REMS certified facility
- Ongoing monitoring and documentation of patient response
- A prescribing psychiatrist or qualified mental health provider
Which Insurers Cover Spravato in 2026
Aetna covers Spravato for adults with treatment resistant depression or MDD with acute suicidal symptoms. Precertification is required for all participating providers. Blue Cross Blue Shield covers Spravato across most state plans. Coverage clarity varies by state. BCBS plans in Utah and Massachusetts maintain straightforward approval pathways. Plans in states like North Carolina and Kansas deny claims more frequently. Cigna covers Spravato for treatment resistant depression after two failed antidepressant trials from different drug classes. Prior authorization is required. UnitedHealthcare covers Spravato after three failed antidepressant trials from at least two different drug classes. The higher threshold means patients need more documented treatment history before qualifying. Medicare Part B covers Spravato when administered in a REMS certified healthcare setting. Medicare typically covers 80% of the approved treatment cost. Patients pay the remaining 20% coinsurance unless supplemental coverage applies. Details on Medicare coverage are available at CMS.gov. Medicaid coverage varies significantly by state. A growing number of state Medicaid programs now include Spravato in their formularies, though prior authorization requirements remain strict.Out of Pocket Costs for IV Ketamine
IV ketamine infusions cost between $400 and $800 per session in 2026. Geographic location drives the biggest price differences. Sessions in Atlanta average around $500. Sessions in California cities range from $600 to $800. A standard initial treatment protocol calls for six sessions over two to three weeks. That puts the total cost for a full introductory course between $2,400 and $4,800. Some providers recommend up to eight initial sessions, pushing the upper range to $6,400. Maintenance infusions follow the initial course. Most patients receive one booster session every four to eight weeks. Annual maintenance costs range from $2,400 to $9,600 depending on frequency and per session pricing.The Insurance Coverage Landscape for Ketamine Treatments
The gap between FDA approved and off label ketamine treatments creates a two tier system for patients. Understanding where each treatment type falls on the coverage spectrum helps patients and providers make informed financial decisions before starting therapy. [INFOGRAPHIC]Financing Options for Patients
CareCredit operates as a healthcare focused credit card accepted at thousands of ketamine clinics. CareCredit offers promotional periods with zero interest if the balance is paid within the promotional window. Prosper Healthcare Lending provides personal loans for medical expenses with fixed interest rates and predictable monthly payments. Loan amounts cover full treatment courses. Clinic payment plans exist at many ketamine providers. Some clinics offer internal financing that breaks the cost of a full treatment course into monthly installments. Patients should ask about payment plans during their initial consultation.Using HSA and FSA Funds for Ketamine
Health Savings Accounts and Flexible Spending Accounts cover ketamine therapy when administered by a licensed provider for a diagnosed medical condition. Both IV ketamine and Spravato qualify as eligible medical expenses under IRS guidelines. Using pretax dollars through an HSA or FSA effectively reduces the cost of treatment by 20% to 35% depending on the patient’s tax bracket. For a $3,000 treatment course, that translates to $600 to $1,050 in tax savings.The Superbill Approach to Partial Reimbursement
A superbill is an itemized invoice that contains diagnosis codes, procedure codes, provider credentials, and session dates. Patients submit superbills to their insurance company for out of network reimbursement consideration. Reimbursement for IV ketamine through superbills is not guaranteed. Insurers frequently deny claims for off label ketamine treatments. Patients who do receive reimbursement typically recover 20% to 50% of costs depending on their plan’s out of network benefits, deductible status, and geographic reimbursement rates.What Clinics Can Do to Help Patients With Costs
- Provide superbills automatically after each session
- Offer package pricing that reduces the per session cost for full treatment courses
- Accept HSA and FSA payments at the point of service
- Partner with CareCredit or similar financing providers
- Create internal payment plans with transparent terms
- Assign a staff member to help patients navigate prior authorization for Spravato
- Maintain REMS certification to offer both Spravato and IV ketamine under one roof
State by State Developments in 2026
Hawaii introduced Senate Bill 967, which would require both Medicaid and private insurers to cover a portion of IV ketamine therapy costs for depression. Missouri introduced House Bill 1043 to establish stricter guidelines for ordering and administering ketamine for mental health. At the federal level, updated Mental Health Parity and Addiction Equity Act (MHPAEA) rules now require insurers to submit detailed analyses of their treatment limitations. Plans must demonstrate that restrictions on mental health treatments apply equally to physical health treatments.Checklist: Questions to Ask Your Insurer About Ketamine Coverage
For Spravato (Esketamine):- Does my plan cover Spravato (esketamine nasal spray)?
- What diagnosis codes qualify for coverage?
- How many failed antidepressant trials does my plan require?
- What is the prior authorization process and typical timeline?
- Does the treating facility need REMS certification?
- What is my copay or coinsurance for each Spravato session?
- Is there a limit on the number of covered sessions per year?
- Does my plan offer out of network benefits for mental health services?
- What is my out of network deductible and have I met it this year?
- What percentage does my plan reimburse for out of network mental health treatment?
- Will my plan accept a superbill for IV ketamine infusion therapy?
- Does my HSA or FSA allow payments for ketamine therapy?
- Do I need a letter of medical necessity from my provider?
- What documentation should I keep for tax purposes?
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
Provider that may work for yous:
